SubHero Banner
Text

October 2023

Core topics in this month’s edition include:

  • Beyfortus (nirsevimab-alip) – drug shortage
  • Cisplatin – foreign drug importation
  • Velsipity (etrasimod) - new drug approval

Download PDF

Text